Andrew Derrick Leaver

Clinigen Ltd. engages in the provision of pharmaceutical products and services. It operates through the following segments: Commercial Medicines, Unlicensed Medicines, and Clinical Trial Services. The Commercial Medicines segment acquires rights to niche hospital-only and critical care products and also provides access to licensed and branded generic. The Unlicensed Medicines segment supplies unlicensed medicines to hospital pharmacists and physicians for patients with a high unmet medical need. The Clinical Trial Services offers comparator medicines and services to clinical trials and IITs. The company was founded by Andrew Leaver in June 2010 and is headquartered in Burton-on-Trent, the United Kingdom.

Bionical Ltd. supplies and manages medicines to the clinical trial, bio-similar and bio-analytical sectors. It provides global clinical trial, sourcing and supply solution. The firm also provides product acquisition services, which include distribution, marketing and management of products. The company was founded by Andrew Derrick Leaver in 2009 and is headquartered in Willington, the United Kingdom.

Clarity Pharma Ltd. provides pharmaceutical licensing and marketing services. The private company is based in Stansted, UK. and has subsidiaries in United Kingdom. The British company was founded by Andrew Derrick Leaver. The CEO is Tanya Monteith.

Fullbrook Thorpe Investments LLP provides investment services. The company is headquartered in Willington, the United Kingdom.